Christopher Jones
Angel · Vermont
Board director at 3 startups that filed Form D raises since late 2024, mostly in Vermont.
- Stages
- Pre-seed to Series A
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Jun 2025
Focus
Biotech & PharmaB2B SoftwareRecent portfolio activity
Sources
- SEC Form D: Causeway TherapeuticsFeb 28, 2023
- SEC Form D: Mountain Spring TechnologiesOct 26, 2023
- SEC Form D: BetaliqJun 2, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.